Prevention of Surgical Site Infections: Decontamination with Mupirocin Based on Preoperative Screening for Staphylococcus aureus Carriers or Universal Decontamination?

Clinical Infectious Diseases

Volumn 62, Issue 5, 2016, Pages 631-636

  Hetem, David J ^a   Bootsma, Martin C J ^a,b   Bonten, Marc J M ^a   Weinstein, Robert A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Decolonization; MRSA; MupA; Mupirocin; Prophylaxis

Indexed keywords

ISOLEUCINE TRANSFER RNA LIGASE; PSEUDOMONIC ACID; CHLORHEXIDINE; OINTMENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BACTERIUM EXAMINATION; BACTERIUM ISOLATE; EPIDEMIOLOGICAL DATA; HORIZONTAL GENE TRANSFER; HOSPITAL ADMISSION; HUMAN; INFECTION PREVENTION; MATHEMATICAL MODEL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; NOSE SMEAR; POINT MUTATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SCREENING; STAPHYLOCOCCUS AUREUS; SURGICAL INFECTION; BATH; BIOLOGICAL MODEL; DECONTAMINATION; DRUG EFFECTS; INTRANASAL DRUG ADMINISTRATION; MICROBIOLOGY; NOSE; OINTMENT; STAPHYLOCOCCAL INFECTIONS; SURGICAL WOUND INFECTION;

ADMINISTRATION, INTRANASAL; BATHS; CHLORHEXIDINE; DECONTAMINATION; DRUG RESISTANCE, BACTERIAL; HUMANS; MODELS, BIOLOGICAL; MUPIROCIN; NOSE; OINTMENTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURGICAL WOUND INFECTION;

EID: 84960146130     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ990     Document Type: Article

References (39)

1. Wertheim HF, Melles DC, Vos MC, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005; 5:751-62.
2. Kluytmans JA, Mouton JW, Ijzerman EP, et al. Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. J Infect Dis 1995; 171:216-9.
3. Kalmeijer MD, van Nieuwland-Bollen E, Bogaers-Hofman D, de Baere GA. Nasal carriage of Staphylococcus aureus is a major risk factor for surgical-site infections in orthopedic surgery. Infect Control Hosp Epidemiol 2000; 21:319-23.
4. Perl TM, Cullen JJ,Wenzel RP, et al. Intranasal mupirocin to prevent postoperative staphylococcus aureus infections. N Engl J Med 2002; 346:1871-7.
5. van Rijen MM, Bonten M, Wenzel RP, Kluytmans JA. Intranasal mupirocin for reduction of staphylococcus aureus infections in surgical patients with nasal carriage: a systematic review. J Antimicrob Chemother 2008; 61:254-61.
6. Bode LG, Kluytmans JA,Wertheim HF, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010; 362:9-17.
7. Schweizer ML, Chiang HY, Septimus E, et al. Association of a bundled intervention with surgical site infections among patients undergoing cardiac, hip, or knee surgery. JAMA 2015; 313:2162-71.
8. Hacek DM, Robb WJ, Paule SM, Kudrna JC, Stamos VP, Peterson LR. Staphylococcus aureus nasal decolonization in joint replacement surgery reduces infection. Clin Orthop Relat Res 2008; 466:1349-55.
9. Kluytmans JA, Manders MJ, van Bommel E, Verbrugh H. Elimination of nasal carriage of Staphylococcus aureus in hemodialysis patients. Infect Control Hosp Epidemiol 1996; 17:793-7.
10. Wassenberg MW, de Wit GA, Bonten MJ. Cost-effectiveness of preoperative screening and eradication of Staphylococcus aureus carriage. PLoS One 2011; 6: e14815.
11. Andriesse GI, van Rijen M, Bogaers D, Bergmans AM, Kluytmans JA. Comparison of two PCR-based methods and conventional culture for the detection of nasal carriage of Staphylococcus aureus in pre-operative patients. Eur J Clin Microbiol Infect Dis 2009; 28:1223-6.
12. Choudhurry RS, Melles DC, Eadie K, et al. Direct detection of human Staphylococcus aureus carriage in the nose using the Lightcycler Staphylococcus kit. J Microbiol Methods 2006; 65:354-6.
13. Luzar MA, Coles GA, Faller B, et al. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N Engl J Med 1990; 322:505-9.
14. White A. Increased infection rates in heavy nasal carriers of coagulasepositive staphylococci. Antimicrob Agents Chemother (Bethesda) 1963; 161: 667-70.
15. Matheson A, Christie P, Stari T, et al. Nasal swab screening for methicillinresistant Staphylococcus aureus-how well does it perform? a cross-sectional study. Infect Control Hosp Epidemiol 2012; 33:803-8.
16. Vivoni AM, Santos KR, de-Oliveira MP, et al. Mupirocin for controlling methicillin-resistant Staphylococcus aureus: lessons from a decade of use at a university hospital. Infect Control Hosp Epidemiol 2005; 26:662-7.
17. Talon D, Marion C, Thouverez M, Bertrand X. Mupirocin resistance is not an inevitable consequence of mupirocin use. J Hosp Infect 2011; 79:366-7.
18. Lee AS, Macedo-Vinas M, Francois P, et al. Trends in mupirocin resistance in meticillin-resistant Staphylococcus aureus and mupirocin consumption at a tertiary care hospital. J Hosp Infect 2011; 77:360-2.
19. Torvaldsen S, Roberts C, Riley TV. The continuing evolution of methicillinresistant Staphylococcus aureus in Western Australia. Infect Control Hosp Epidemiol 1999; 20:133-5.
20. Riley TV, Carson CF, Bowman RA, et al. Mupirocin-resistant methicillinresistant Staphylococcus aureus in Western Australia. Med J Aust 1994; 161: 397-8.
21. Boelaert JR, De Smedt RA, De Baere YA, et al. The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in haemodialysis patients. Nephrol Dial Transplant 1989; 4:278-81.
22. Annigeri R, Conly J, Vas S, et al. Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit Dial Int 2001; 21:554-9.
23. Perez-Fontan M, Rodriguez-Carmona A, Rosales M, Garcia-Falcon T, Valdes F. Incidence and clinical significance of nasal and pericatheter colonization by gram-negative bacteria among patients undergoing chronic peritoneal dialysis. Nephrol Dial Transplant 2002; 17:118-22.
24. Hetem DJ, Bonten MJ. Clinical relevance of mupirocin resistance in Staphylococcus aureus. J Hosp Infect 2013; 85:249-56.
25. Lee AS, Macedo-Vinas M, Francois P, et al. Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant Staphylococcus aureus carriage after decolonization therapy: a case-control study. Clin Infect Dis 2011; 52:1422-30.
26. Fawley WN, Parnell P, Hall J, Wilcox MH. Surveillance for mupirocin resistance following introduction of routine peri-operative prophylaxis with nasal mupirocin. J Hosp Infect 2006; 62:327-32.
27. Hetem DJ, Vogely HC, Severs TT, Troelstra A, Kusters JG, Bonten MJ. Acquisition of high-level mupirocin resistance in CoNS following nasal decolonization with mupirocin. J Antimicrob Chemother 2015; 70:1182-4.
28. Hurdle JG, O'Neill AJ, Mody L, Chopra I, Bradley SF. In vivo transfer of high-level mupirocin resistance from Staphylococcus epidermidis to methicillin-resistant Staphylococcus aureus associated with failure of mupirocin prophylaxis. J Antimicrob Chemother 2005; 56:1166-8.
29. Petinaki E, Spiliopoulou I, Kontos F, et al. Clonal dissemination of mupirocinresistant staphylococci in Greek hospitals. J Antimicrob Chemother 2004; 53:105-8.
30. Horner C, Mawer D, Wilcox M. Reduced susceptibility to chlorhexidine in staphylococci: is it increasing and does it matter? J Antimicrob Chemother 2012; 67:2547-59.
31. Sekiguchi J, Hama T, Fujino T, et al. Detection of the antiseptic-and disinfectantresistance genes qacA, qacB, and qacC in methicillin-resistant Staphylococcus aureus isolated in a Tokyo hospital. Jpn J Infect Dis 2004; 57:288-91.
32. Hetem DJ, Bootsma MC, Troelstra A, Bonten MJ. Transmissibility of livestockassociated methicillin-resistant Staphylococcus aureus. Emerg Infect Dis 2013; 19:1797-802.
33. McBryde ES, Pettitt AN, McElwain DL. A stochastic mathematical model of methicillin resistant Staphylococcus aureus transmission in an intensive care unit: predicting the impact of interventions. J Theor Biol 2007; 245:470-81.
34. Agvald-Ohman C, Lund B, Edlund C. Multiresistant coagulase-negative staphylococci disseminate frequently between intubated patients in a multidisciplinary intensive care unit. Crit Care 2004; 8:R42-7.
35. Huang SS, Septimus E, Kleinman K, et al. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 2013; 368:2255-65.
36. Phillips M, Rosenberg A, Shopsin B, et al. Preventing surgical site infections: a randomized, open-label trial of nasal mupirocin ointment and nasal povidone-iodine solution. Infect Control Hosp Epidemiol 2014; 35:826-32.
37. Poovelikunnel T, Gethin G, Humphreys H. Mupirocin resistance: clinical implications and potential alternatives for the eradication of MRSA. J Antimicrob Chemother 2015; 70:2681-92.
38. Kline S, Highness M, Herwaldt LA, Perl TM. Variable screening and decolonization protocols for Staphylococcus aureus carriage prior to surgical procedures. Infect Control Hosp Epidemiol 2014; 35:880-2.
39. Diekema D, Johannsson B, Herwaldt L, et al. Current practice in Staphylococcus aureus screening and decolonization. Infect Control Hosp Epidemiol 2011; 32:1042-4.